Style | Citing Format |
---|---|
MLA | Mokhtari S, et al.. "Protective Assessment of Progesterone and Its Receptor on Experimental Diabetic Neuropathy: Antioxidant and Anti-Inflammatory Effects." Fundamental and Clinical Pharmacology, vol. 37, no. 2, 2023, pp. 287-295. |
APA | Mokhtari S, Sistani Karampour N, Shams MH, Dehpour AR, Hasanvand A (2023). Protective Assessment of Progesterone and Its Receptor on Experimental Diabetic Neuropathy: Antioxidant and Anti-Inflammatory Effects. Fundamental and Clinical Pharmacology, 37(2), 287-295. |
Chicago | Mokhtari S, Sistani Karampour N, Shams MH, Dehpour AR, Hasanvand A. "Protective Assessment of Progesterone and Its Receptor on Experimental Diabetic Neuropathy: Antioxidant and Anti-Inflammatory Effects." Fundamental and Clinical Pharmacology 37, no. 2 (2023): 287-295. |
Harvard | Mokhtari S et al. (2023) 'Protective Assessment of Progesterone and Its Receptor on Experimental Diabetic Neuropathy: Antioxidant and Anti-Inflammatory Effects', Fundamental and Clinical Pharmacology, 37(2), pp. 287-295. |
Vancouver | Mokhtari S, Sistani Karampour N, Shams MH, Dehpour AR, Hasanvand A. Protective Assessment of Progesterone and Its Receptor on Experimental Diabetic Neuropathy: Antioxidant and Anti-Inflammatory Effects. Fundamental and Clinical Pharmacology. 2023;37(2):287-295. |
BibTex | @article{ author = {Mokhtari S and Sistani Karampour N and Shams MH and Dehpour AR and Hasanvand A}, title = {Protective Assessment of Progesterone and Its Receptor on Experimental Diabetic Neuropathy: Antioxidant and Anti-Inflammatory Effects}, journal = {Fundamental and Clinical Pharmacology}, volume = {37}, number = {2}, pages = {287-295}, year = {2023} } |
RIS | TY - JOUR AU - Mokhtari S AU - Sistani Karampour N AU - Shams MH AU - Dehpour AR AU - Hasanvand A TI - Protective Assessment of Progesterone and Its Receptor on Experimental Diabetic Neuropathy: Antioxidant and Anti-Inflammatory Effects JO - Fundamental and Clinical Pharmacology VL - 37 IS - 2 SP - 287 EP - 295 PY - 2023 ER - |